Citigroup Inc. set a €123.00 ($146.43) price objective on Merck KGaA (FRA:MRK) in a research note released on Wednesday morning. The firm currently has a buy rating on the healthcare company’s stock.

Other research analysts have also issued reports about the company. Berenberg Bank set a €116.00 ($138.10) price target on Merck KGaA and gave the stock a buy rating in a report on Wednesday. J P Morgan Chase & Co reiterated a neutral rating on shares of Merck KGaA in a report on Wednesday, September 6th. Commerzbank Ag set a €109.00 ($129.76) price target on Merck KGaA and gave the stock a neutral rating in a report on Wednesday, September 6th. Independent Research GmbH set a €105.00 ($125.00) price target on Merck KGaA and gave the stock a neutral rating in a report on Wednesday, September 6th. Finally, Bank of America Corporation set a €110.00 ($130.95) price target on Merck KGaA and gave the stock a buy rating in a report on Wednesday, September 6th. Thirteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of €108.38 ($129.02).

Shares of Merck KGaA (FRA:MRK) opened at 96.97 on Wednesday. Merck KGaA has a 52 week low of €89.00 and a 52 week high of €115.00. The company has a market cap of €42.16 billion and a price-to-earnings ratio of 25.28. The company has a 50 day moving average of €93.29 and a 200-day moving average of €102.45.

WARNING: “Citigroup Inc. Reiterates “€123.00” Price Target for Merck KGaA (MRK)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/16/citigroup-inc-reiterates-123-00-price-target-for-merck-kgaa-mrk.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.